BioHealth Capital Region – Regional Life Sciences Roundup – November 5, 2026
This week brings changes in biotech businesses alongside practical routes into genetic testing and manufacturing careers. The connection is preparation for what comes next, whether that means combining companies, making testing available at no cost to eligible patients, or helping people learn the work of biomanufacturing. Those changes show up at different scales, from a completed merger to a four-week classroom program.
Supernus and Indivior completed their merger, while GeneDx and Mirum Pharmaceuticals launched sponsored genetic testing programs. Their collaboration provides no-cost exome testing for eligible patients with unexplained cholestasis, early-onset cataracts, or certain peroxisomal disorders. In Norfolk, Virginia, ReAlta Life Sciences launched KnowHIE, an educational resource for families of babies diagnosed with hypoxic ischemic encephalopathy. Testing access and family education are distinct efforts, both focused on helping people navigate difficult diagnostic territory.
The people side is moving too. Frederick Community College’s eighth Biotech Boot Camp cohort brings students, working professionals, and people displaced by layoffs into a free program requiring no prior experience. BioHub Maryland’s Baltimore manufacturing event offered another route into the field through professional presentations and a laboratory tour.
Financial
Tracking the capital moving through the BioHealth Capital Region: funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader | Supernus Pharmaceuticals
Supernus announced completion of its merger with Indivior on November 2, 2026, in Rockville, Maryland. The combined company operates as Supernus, , with an 11-product portfolio and was scheduled to begin Nasdaq trading under SUPN on November 3. Read More >
Emergent BioSolutions Receives $22.3 Million Delivery Order to the U.S. Department of War
Gaithersburg, Maryland’s Emergent BioSolutions received a delivery order modification valued at up to 3 million to supply BioThrax® to the S. Department of War. An initial delivery valued at approximately 4 million will begin in 2026, with remaining deliveries expected in 2027. Read More >
Samsung Biologics Logs $323M Contract as Biosecure Act Redirection Enters Procurement Data
Samsung Biologics disclosed a biologics manufacturing contract with an undisclosed global pharmaceutical client. The agreement begins November 2, 2026, and runs through December 31, with the customer remaining unnamed in the contract announcement. Read More >
People
Who we’re buzzing about this week: the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
TEDCO Board Names Lester Davis Interim Chief Executive Officer
The Maryland Technology Development Corporation’s board named Lester Davis interim chief executive officer. Davis takes on the organization’s top executive role on an interim basis following the board’s selection to lead the organization. Read More >
RPM Tech adds business development strategist in its 20th year
Roanne Yehia joined RPM Tech as business development and innovation strategist in Forest Hill, Maryland. The engineer and medtech founder will focus on company growth, strategic partnerships, and operational strategy as the product development and manufacturing firm marks 20 years. Read More >
Who is NovaBridge Biosciences bringing in to lead its finances?
NovaBridge Biosciences appointed Chuck Silberstein as chief financial officer. Silberstein joins the company’s executive leadership in the finance role, taking the chief financial officer position as the company’s newly named financial executive. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
Frederick Community College runs a free biotech training program, here’s who taught the latest cohort
Frederick Community College’s eighth Biotech Boot Camp cohort trained with Alexandra Bezilla, the program’s primary instructor for fall 2026. The free, four-week program requires no prior experience and teaches practical skills including aseptic technique, pipetting, documentation, and professional communication. Read More >
Bringing the Classroom to Industry: A Student’s Perspective on Biopharma Manufacturing
BioHub Maryland introduced attendees to biopharmaceutical manufacturing at Baltimore’s 4MLK Building on October 13, 2026. The event combined professional presentations with a tour of Connect Labs by Wexford, connecting classroom learning with manufacturing processes and career paths. Read More >
Who’s Hiring
Who’s HiringTOP EMPLOYER |
||||||
|
||||||
| View all jobs on BioBuzz |
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
Elutia raises $26 million as plastic surgeons flag infection concern at national meeting
Elutia received $26 million without an equity offering and plans a fourth-quarter 2026 Food and Drug Administration submission for investigational NXT-41x. The company expects the capital to fund operations through anticipated clearance and its first full year of commercialization in 2028. Read More >
Three no-cost exome programs now open: which rare diseases are covered?
GeneDx, in Gaithersburg, Maryland, and Mirum Pharmaceuticals launched three sponsored programs offering eligible patients no-cost exome testing. The programs cover unexplained cholestasis, early-onset cataracts, and suspected or confirmed peroxisomal biogenesis disorder, Zellweger spectrum disorders. Read More >
ReAlta Life Sciences creates online resource for families facing HIE diagnosis in newborns
ReAlta Life Sciences launched KnowHIE, an online educational resource for families of babies diagnosed with hypoxic ischemic encephalopathy. The clinical-stage biopharmaceutical company in Norfolk, Virginia, created the resource with those families as its intended audience. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure, and the organizations driving it forward.
Gaithersburg’s Vector BioMed recognized for lentiviral work across Asia
Life Sciences Review named Gaithersburg, Maryland’s Vector BioMed its Lentiviral Vector Design and Manufacturing Company of the Year in Asia 2026. Vector BioMed says it has served more than 40 clients and focuses exclusively on lentiviral vectors for cell and gene therapy development. Read More >
CellectGen Advances Periodontal Diagnostics in Collaboration with Kemp Proteins and DCNDx
CellectGen received Small Business Innovation Research funding to develop a saliva-based, point-of-care diagnostic platform for periodontal disease. The Pasadena, California, company is collaborating with Kemp Proteins and DCNDx, including antibody development work intended to distinguish molecular forms associated with tissue destruction. Read More >
Beyond the Bench: How Mentorship and Community Connections Help Build Biotech Careers | BioBuzz
Kirsten Bowland described her move from academic research into biotech company building at a Women in Bio Capital Region coffee chat. At the October 21 event, she shared how community connections led to contracting work with three companies at Children’s National Research & Innovation Campus. Read More >
HJF Team Supporting ACESO Transitions to ATLAS, Expanding its Mission Focus Across Severe Infection Domains
The Henry M. Jackson Foundation for the Advancement of Military Medicine renamed its team supporting the Navy’s sepsis research program ATLAS, effective November 2, 2026. The team’s focus expands beyond sepsis to trauma and severe infections in resource-limited environments. Read More >
Other [Good] Reads
Editor’s picks from across the web: the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
BullFrog AI’s CEO explains the company’s approach to drug target discovery
Vin Singh, founder, chairman, and CEO of BullFrog AI, discussed drug target discovery and patient selection in an Oxford Global interview. He described the company’s focus on causal artificial intelligence and integrating multiple data types to inform drug development decisions. Read More >
New whitepaper reveals 3 process steps Samsung adjusted per cell line for S-Tensify
Samsung Biologics explores cell-line-specific process optimization in a whitepaper focused on advancing S-Tensify™. The paper centers on tailoring processes to individual cell lines, with S-Tensify™ development as its focus rather than a broader company update. Read More >
What keeps Maryland’s 51,705 bioscience workers ahead of competing states?
Maryland’s bioscience industry employed 51,705 people, according to a report from the Biotechnology Innovation Organization and TEConomy Partners. The Maryland Tech Council highlighted an average bioscience wage of $158,000 and nearly $3 billion in academic research, alongside competitive challenges. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
Single Cell RNA-Seq
Monday, November 16 · 4:00 AM · Germantown, MD, Workshop / Training / Class
GxP Auditing Logistics and Inspection Readiness Training Course (Including Mock Activity) (PDA 298)
Monday, November 16 · Bethesda, MD, Workshop / Training / Class
Big Idea CONNECTpreneur Baltimore Forum
Thursday, November 12 · 8:00 AM · Networking / Mixer / Social
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.
